Agmatine sulfate,
does it really help with Improved workout pump, blood flow, and endurance?
research showsAgmatine is an arginine metabolite used in pre-workout products because it may modulate nitric-oxide signaling. However, a full peer-reviewed human efficacy trial evaluating muscle blood flow or pump during exercise, endurance, or resistance-training adaptation was essentially not identified. A 2022 conference abstract found no difference from placebo in any performance, fatigue, lactate, or perceived-exertion outcome after a single 1 g dose during repeated Wingate tests, but it is not a full paper. The target efficacy literature remains insufficiently established, so the grade is ?.
ads claimAdvertising presents possible nitric-oxide modulation and subjective pump as increased blood flow, longer pump, and better endurance. Mechanistic plausibility is not an exercise-performance, ultrasound blood-flow, or training-adaptation outcome.
Useful facts when choosing a product
- In Korea, agmatine is mainly available through cross-border powder or capsules and in pre-workout combinations; a standalone powder label recommends about 1 g per serving.
- Combination pre-workouts containing caffeine, citrulline, or beta-alanine cannot isolate an agmatine effect.
- The 2.67 g/day used in the radiculopathy trial is not an exercise-efficacy dose, and diarrhea and nausea occurred during higher-dose escalation.
- Interactions with blood-pressure drugs, glucose-lowering drugs, nitrates, erectile-dysfunction medication, and neurologic drugs, and long-term exercise-use safety, remain insufficiently studied.
What the research actually shows
The 2018 ISSN research and recommendations review by Kerksick and colleagues stated that nearly all agmatine research involved animal models, with no human study of blood flow or resistance-training adaptations such as strength and body composition and no evidence supporting increases in lean mass or muscular performance. The 2010 trial by Keynan and colleagues administered 2.67 g/day for 14 days to patients with lumbar disc-associated radiculopathy and was a pain study rather than an exercise trial. A 2022 conference abstract by Helton and colleagues gave physically active college-age men 1 g of agmatine sulfate or placebo in a crossover design before three 15-second Wingate tests. Mean and peak watts, anaerobic capacity and power, fatigue index, heart rate, lactate, and perceived exertion were all nonsignificant. No full paper or exercise muscle-blood-flow measurement was identified.
Why this is classified as ?
A complete human efficacy literature appropriately evaluating workout pump, blood flow, or endurance is essentially absent, so the grade is ?. The null single-dose conference abstract is noted but is not treated as a large, replicated, full null trial warranting D or F. Safety is separately rated caution.
Counterpoint. Mechanistic and human-exposure data from another indication support testability. An adequately powered independent RCT should prospectively specify ultrasound blood flow, training volume, time trial, and repeated-performance outcomes.
Rejudgment record. New verdict — No full peer-reviewed human efficacy literature for workout pump, blood flow, or endurance; a null single-dose conference abstract was treated as contextual only
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Kerksick et al. 2018 ISSN review | Sports-nutrition research and recommendations review | ISSN; authors disclosed diverse industry relationships | Human evidence for exercise blood flow, strength, body composition, and muscular performance | Stated that relevant human trials were absent and no scientific evidence supported lean-mass or muscular-performance benefits. | Key | |
| Keynan et al. 2010 | Dose escalation followed by a randomized double-blind placebo-controlled pain trial | 61 | Unknown | Radiculopathy pain, disability, quality of life, and safety | Pain signals at 2.67 g/day; workout pump, blood flow, and endurance were not evaluated. | Indirect |
| Helton et al. 2022 conference abstract | Randomized counterbalanced single-dose crossover conference abstract | Unknown | Three 15-second Wingate tests, fatigue, heart rate, lactate, and perceived exertion | No reported outcome differed between 1 g agmatine and placebo; no full paper was identified. | Preliminary and indirect |
Receipt — 3 References
Of 3 cited sources, 1 had limited original-page access (blocked or summary-only) and were verified via index/summary, marked partial; the rest were verified at the original page. As of 2026-07-16.
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-16 · Corrections: none
Cite this verdict
[Chamgap] Agmatine sulfate x workout pump, blood flow, and endurance — Evidence Grade ?. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/sports/agmatine-sulfate-workout-pump-blood-flow-endurance/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.